Table 3.
Univariate Cox regression analysis for PFS
Variable | HR (95% CI) | p Value |
---|---|---|
Age | 1.01(1.00–1.02) | 0.187 |
Gender | 1.34(0.92–1.94) | 0.128 |
KPS | 1.00(0.98–1.01) | 0.733 |
KPS < 70 | 0.84(0.41–1.73) | 0.639 |
Duration of symptoms | 1.02(1.00–1.04) | 0.108 |
Headache | 0.86(0.60–1.25) | 0.438 |
Nausea/vomiting | 1.01(0.58–1.77) | 0.967 |
Motor deficit | 1.02(0.72–1.45) | 0.915 |
Sensory deficit | 0.66(0.35–1.23) | 0.187 |
Seizures | 1.05(0.73–1.51) | 0.796 |
Language deficit | 0.98(0.68–1.43) | 0.926 |
Visual impairment | 0.92(0.58–1.46) | 0.728 |
Ataxia/gait deficit | 0.94(0.65–1.35) | 0.733 |
Cognition deficit | 1.01(0.71–1.44) | 0.967 |
Altered level of consciousness | 0.71(0.29–1.74) | 0.453 |
Midline Structures Involvement | 2.80 (1.67–4.74) | < 0.001 |
Left hemisphere | 0.90(0.63–1.28) | 0.549 |
Preoperative tumor volume | 1.00(0.99–1.01) | 0.657 |
RTV | 1.17(1.09–1.26) | < 0.001 |
EOR | 0.97(0.95–0.99) | 0.001 |
Duration of hospitalisation | 1.00(0.95–1.04) | 0.835 |
Duration of the operation | 1.00(1.00–1.00) | 0.885 |
Ki-67 | 1.00(0.99–1.01) | 0.910 |
Ki-67 < 15 | 1.32(0.78–2.23) | 0.309 |
MGMT | 1.35(0.93–1.94) | 0.111 |